About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Recurrence of Breast Cancer can Now be Predicted by a Simple Blood Test
Advertisement

Recurrence of Breast Cancer can Now be Predicted by a Simple Blood Test

Font : A-A+

Highlights
  • A simple blood test that detects tumor cells circulating in the blood can now predict high or low risk of a breast cancer relapse
  • The use of circulating tumor cells (CTCs) blood test has now been approved for physicians use to monitor response to treatment in advanced breast, colon or prostate cancer patients
  • Positive CTC test was associated with a 35 percent increase in breast cancer recurrence

High to moderate risk of Breast cancer relapse can now be predicted by a simple blood test which identifies circulating tumor cell in patient blood samples. The findings of this study were extensively discussed in 40th annual San Antonio Breast Cancer Symposium.

A proof-of-concept study by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) measured the prevalence of circulating tumor cells (CTCs) in blood samples from patients cancer-free five years or more after diagnosis, then associated CTC presence with a later recurrence.

Advertisement


"Late recurrence five or more years after surgery accounts for at least one-half of recurrences of breast cancer, and there are no tests that identify who is at highest risk. We found that in women who were cancer-free five years after diagnosis, about 5 percent had a positive CTC test," said lead researcher Joseph A. Sparano, MD, vice chair of the ECOG-ACRIN Cancer Research Group, Philadelphia, and associate director for clinical research at Montefiore Medical Center, Albert Einstein Cancer Center, New York.

"More importantly", Dr. Sparano continued, "we also found that a positive test was associated with a 35 percent recurrence risk after two years, compared with only 2 percent for those with a negative CTC test."
Advertisement

The concept is to explore the use of the CTC blood test in a new way. Currently, the test is FDA-approved for use by physicians to monitor response to treatment in patients with advanced breast, colon or prostate cancer, but not early stage cancer.

A rise in the number of circulating tumor cells in the blood in patients with advanced disease may indicate trouble before it shows up on a scan. In this study, the research team evaluated this test in a different setting individuals alive and cancer-free about five years after their diagnosis and potentially cured, but still at risk for having a recurrence of their disease.

"Our ultimate goal is to use blood tests like this to tailor treatment in a way that minimizes recurrence risk for those at high risk, and spare treatment for those at low risk who may be unlikely to benefit from it," Dr. Sparano said. "The findings of this analysis provide strong evidence to further evaluate this new risk assessment approach using CTC and other blood-based tests in this setting".

The test was done on a single blood sample provided by 547 breast cancer patients who had been diagnosed more than five years prior and treated as part of a large ECOG-ACRIN breast cancer treatment trial, E5103. This group of patients had stage two or three breast cancer, and the cells in their tumors were HER2-negative.

Many women in E5103 remain cancer free and are being followed for their breast cancer status as part of standard care. Dr. Sparano and colleagues set up a biobank and invited these patients to contribute additional specimens for future research into the reasons for late recurrence.

The biobank was established by ECOG-ACRIN and the Coalition of Cancer Cooperative Groups with funding from the Breast Cancer Research Foundation, National Cancer Institute, and Susan G. Komen. This analysis is the first read-out from the biobank.

Reference

Blood Test May Predict Breast Cancer Recurrence - (http://ecog-acrin.org/news-and-info/press-releases/joseph-sparano-circulating-tumor-cells-may-predict-breast-cancer-recurrence)

Source: Eurekalert

Citations   close

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rishika Gupta. (2017, December 09). Recurrence of Breast Cancer can Now be Predicted by a Simple Blood Test. Medindia. Retrieved on Sep 25, 2022 from https://www.medindia.net/news/healthwatch/recurrence-of-breast-cancer-can-now-be-predicted-by-a-simple-blood-test-175364-1.htm.

  • MLA

    Rishika Gupta. "Recurrence of Breast Cancer can Now be Predicted by a Simple Blood Test". Medindia. Sep 25, 2022. <https://www.medindia.net/news/healthwatch/recurrence-of-breast-cancer-can-now-be-predicted-by-a-simple-blood-test-175364-1.htm>.

  • Chicago

    Rishika Gupta. "Recurrence of Breast Cancer can Now be Predicted by a Simple Blood Test". Medindia. https://www.medindia.net/news/healthwatch/recurrence-of-breast-cancer-can-now-be-predicted-by-a-simple-blood-test-175364-1.htm. (accessed Sep 25, 2022).

  • Harvard

    Rishika Gupta. 2021. Recurrence of Breast Cancer can Now be Predicted by a Simple Blood Test. Medindia, viewed Sep 25, 2022, https://www.medindia.net/news/healthwatch/recurrence-of-breast-cancer-can-now-be-predicted-by-a-simple-blood-test-175364-1.htm.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge About Chromosomes?
Eating During Sunlight Hours Minimizes Mood Vulnerabilities
Know More About the Digestive System
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Breast Biopsy Thalassemia Pagets disease of the breast Mastitis Cancer and Homeopathy Undescended Testicles Breast Cancer Facts Cancer Facts Cancer 

Most Popular on Medindia

Drug Interaction Checker Blood - Sugar Chart Diaphragmatic Hernia Find a Doctor Indian Medical Journals Blood Pressure Calculator Drug Side Effects Calculator Daily Calorie Requirements Drug - Food Interactions Find a Hospital
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Recurrence of Breast Cancer can Now be Predicted by a Simple Blood Test Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests